161 related articles for article (PubMed ID: 34153320)
21. Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.
Daly C; Qian X; Castanaro C; Pasnikowski E; Jiang X; Thomson BR; Quaggin SE; Papadopoulos N; Wei Y; Rudge JS; Thurston G; Yancopoulos GD; Davis S
Sci Rep; 2018 Jan; 8(1):505. PubMed ID: 29323190
[TBL] [Abstract][Full Text] [Related]
22. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
[TBL] [Abstract][Full Text] [Related]
23. Tie1: an orphan receptor provides context for angiopoietin-2/Tie2 signaling.
Mueller SB; Kontos CD
J Clin Invest; 2016 Sep; 126(9):3188-91. PubMed ID: 27548526
[TBL] [Abstract][Full Text] [Related]
24. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
Song SH; Kim KL; Lee KA; Suh W
Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
[TBL] [Abstract][Full Text] [Related]
25. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.
Saito M; Watanabe J; Fujisawa T; Kamata Y; Nishimura Y; Arai T; Miyamoto T; Obokata A; Kuramoto H
Eur J Gynaecol Oncol; 2006; 27(2):129-34. PubMed ID: 16620053
[TBL] [Abstract][Full Text] [Related]
27. A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function.
White RR; Roy JA; Viles KD; Sullenger BA; Kontos CD
Angiogenesis; 2008; 11(4):395-401. PubMed ID: 19037734
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Tie2-α
Shlamkovich T; Aharon L; Koslawsky D; Einav Y; Papo N
BMC Biol; 2018 Aug; 16(1):92. PubMed ID: 30119679
[TBL] [Abstract][Full Text] [Related]
29. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.
Akwii RG; Sajib MS; Zahra FT; Mikelis CM
Cells; 2019 May; 8(5):. PubMed ID: 31108880
[TBL] [Abstract][Full Text] [Related]
30. Effect of HIV-1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial Dysfunction.
Thakkar AB; Ma Y; Dela Cruz M; Wu Y; Arechiga V; Swaminathan S; Ganz P; Wu AHB; Scherzer R; Deeks S; Hsue PY
J Am Heart Assoc; 2021 Nov; 10(22):e021397. PubMed ID: 34726064
[TBL] [Abstract][Full Text] [Related]
31. Regulation of tie2 expression by angiopoietin--potential feedback system.
Hashimoto T; Wu Y; Boudreau N; Li J; Matsumoto M; Young W
Endothelium; 2004; 11(3-4):207-10. PubMed ID: 15370298
[TBL] [Abstract][Full Text] [Related]
32. Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Falcón BL; Hashizume H; Koumoutsakos P; Chou J; Bready JV; Coxon A; Oliner JD; McDonald DM
Am J Pathol; 2009 Nov; 175(5):2159-70. PubMed ID: 19815705
[TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment.
Kobayashi H; DeBusk LM; Babichev YO; Dumont DJ; Lin PC
Blood; 2006 Aug; 108(4):1260-6. PubMed ID: 16638932
[TBL] [Abstract][Full Text] [Related]
34. [Expression and significance of Ang1, Ang2 and receptor Tie2 in hemangioma].
Wang B; Lu KH; Zhao YN; Zhuang FL; Hong F; Lin WX; Lin JA; Zhang S
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 Nov; 23(6):515-8. PubMed ID: 18269030
[TBL] [Abstract][Full Text] [Related]
35. VEGF induces Tie2 shedding via a phosphoinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling.
Findley CM; Cudmore MJ; Ahmed A; Kontos CD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2619-26. PubMed ID: 17901375
[TBL] [Abstract][Full Text] [Related]
36. Angiopoietins contribute to lung development by regulating pulmonary vascular network formation.
Hato T; Kimura Y; Morisada T; Koh GY; Miyata K; Tabata M; Kadomatsu T; Endo M; Urano T; Arai F; Araki K; Suda T; Kobayashi K; Oike Y
Biochem Biophys Res Commun; 2009 Apr; 381(2):218-23. PubMed ID: 19217887
[TBL] [Abstract][Full Text] [Related]
37. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis.
Fukuhara S; Sako K; Noda K; Zhang J; Minami M; Mochizuki N
Histol Histopathol; 2010 Mar; 25(3):387-96. PubMed ID: 20054809
[TBL] [Abstract][Full Text] [Related]
38. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
39. Endothelial permeability following coronary artery bypass grafting: an observational study on the possible role of angiopoietin imbalance.
Hilbert T; Duerr GD; Hamiko M; Frede S; Rogers L; Baumgarten G; Hoeft A; Velten M
Crit Care; 2016 Mar; 20():51. PubMed ID: 26951111
[TBL] [Abstract][Full Text] [Related]
40. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation.
Kim M; Allen B; Korhonen EA; Nitschké M; Yang HW; Baluk P; Saharinen P; Alitalo K; Daly C; Thurston G; McDonald DM
J Clin Invest; 2016 Sep; 126(9):3511-25. PubMed ID: 27548529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
